External link, please review our disclaimer.

NIDA Genetics Consortium (NGC)

What We Do:

The NIDA Genetics Consortium was created in 1999 and has several overarching missions:

  • Identify human chromosomal regions containing genes and/or specific genes that confer susceptibility to drug addiction
  • Create a repository for data (i.e., clinical information and biospecimens containing DNA) that are contributed by multiple studies, so as to permit pooling of data to maximize statistical power
  • Generate a database on molecular genetics of drug use disorders and related phenotypes to provide controlled access for collaborative studies with the broader scientific community
  • Establish a consortium of scientists who meet regularly and collaborate on projects

Research Interests:

NIDA has created a list of domains and their associated measures to help with the harmonization of data in the area of genetic studies.

Policies for access and distribution of DNA and clinical data from NIDA-funded studies on the genetics of addiction vulnerability



Any questions or concerns regarding the Human Genetics Consortium please contact Joni Rutter Ph.D.

This page was last updated April 5, 2012.

Featured Publication

Featured Publication

Drugs, Brains, and Behavior - The Science of Addiction

As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site